Loading...
IVCR.Q logo

Invacare CorporationOTCPK:IVCR.Q 株式レポート

時価総額 US$512.8k
株価
n/a
1Y-99.1%
7D-10.6%
1D-6.9%
ポートフォリオ価値
​
表示

Invacare Corporation

OTCPK:IVCR.Q 株式レポート

時価総額：US$512.8k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Invacare（IVCR.Q）株式概要

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. 詳細

IVCR.Q ファンダメンタル分析
スノーフレーク・スコア
評価2/6
将来の成長0/6
過去の実績0/6
財務の健全性1/6
配当金0/6

リスク分析

過去5年間で収益は年間2.6%減少しました。

意味のある時価総額がありません ( $513K )

US市場と比較して、過去 3 か月間の株価の変動が非常に大きい

キャッシュランウェイが1年未満である

+1 さらなるリスク

IVCR.Q Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW475,857 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
DA
davidlsander
475,857 investors already sharing narratives
View all narratives

Invacare Corporation 競合他社

価格と性能

株価の高値、安値、推移の概要Invacare
過去の株価
現在の株価US$0.013
52週高値US$1.64
52週安値US$0.011
ベータ0.51
1ヶ月の変化-10.00%
3ヶ月変化-62.60%
1年変化-99.09%
3年間の変化-99.77%
5年間の変化-99.92%
IPOからの変化-99.49%

最新ニュース

Recent updates

Seeking Alpha • Feb 01

Invacare falls on bankruptcy filing

Medical equipment maker Invacare Corporation (NYSE:IVC) lost ~20% in the pre-market trading Wednesday after announcing that the company and two U.S.-based subsidiaries filed for voluntary Chapter 11 bankruptcy. The cases, filed in the Bankruptcy Court for the Southern District of Texas, do not include its international operations and are not expected to impact the company’s ability to serve its global clientele, Invacare (IVC) said. The bankruptcy cases follow a financial restructuring agreement the company inked with almost all of its debt holders and most of the convertible noteholders. The deal, known as Restructuring Support Agreement, allows Invacare (IVC) to reduce its debt by ~$240M and provides the company with $60M equity capital to repay certain debt and fund its transformation plan. “The company expects to emerge with significantly less debt on its balance sheet and will secure additional liquidity to support long-term growth,” Invacare’s (IVC) recently appointed Chief Executive Geoff Purtill noted.
Seeking Alpha • Dec 27

Invacare announces additional draw of $5.5M term loans

Invacare (NYSE:IVC) announced additional draw of $5.5M of term loans under its credit agreement. The company said certain funds will be managed by Highbridge Capital Managed. The company will use the proceeds of the additional draw for general corporate purposes, it said. About $14M of additional liquidity remains available under the Amended Highbridge Credit Agreement, subject to satisfaction of certain conditions set forth therein.
分析記事 • Nov 14

Invacare Corporation (NYSE:IVC) Analysts Just Slashed Next Year's Estimates

Market forces rained on the parade of Invacare Corporation ( NYSE:IVC ) shareholders today, when the analysts...
Seeking Alpha • Nov 07

Invacare GAAP EPS of -$0.92, revenue of $170.4M

Invacare press release (NYSE:IVC): Q3 GAAP EPS of -$0.92. Revenue of $170.4M (-24.0% Y/Y). Gross margin was 18.4%, a decrease of 850 basis points, including 510 basis points of decline related to the write-down of respiratory inventory as a result of the decision to discontinue production of respiratory products. SG&A expense decreased 1.4% to $55.4 million, and constant currency SG&A increased 4.5%. Operating loss was $33.4 million compared to a loss of $24.8 million. Adjusted EBITDA loss was $11.8 million, compared to positive $8.0 million. Free cash flow usage was $20.5 million compared to usage of $6.1 million.
Seeking Alpha • Sep 29

Invacare receives non-compliance letter from NYSE

Invacare (NYSE:IVC) said on Thursday it had received notice from the New York Stock Exchange that it was not in compliance with the NYSE listed company manual as the average closing price was less than $1 per share over a consecutive 30 trading-day period. The company plans to notify the NYSE by October 7 on its plan to return to compliance with the NYSE continued listing standard. The company can regain compliance at any time within the six-month period. The company is required to have a closing share price of at least $1 over a consecutive 30 trading-day period. The company intends to consider available alternatives, including, but not limited to, a reverse stock split, subject to shareholder approval no later than at the company’s next annual meeting of shareholders.
Seeking Alpha • Aug 29

Invacare names Geoffrey Purtill as interim president and executive chief

Invacare (NYSE:IVC) on Monday has named Geoffrey P. Purtill as the company's interim president and chief executive officer, succeeding departing chairman, president and CEO Matthew E. Monaghan. The transition is effective Aug. 28, 2022. Geoffrey P. Purtill had been serving as the Invacare's senior vice president and general manager, EMEA and APAC.  "We welcome Geoff who has distinguished himself throughout his tenure with Invacare. The Board has full confidence that he has the right skillset and industry experience to lead the company through this transition as we search for a permanent successor who can accelerate the achievement of our objectives," said Cliff Nastas, Invacare’s lead independent director. In addition, the Board has announced the appointment of Michael J. Merriman as its director and non-executive Chairman. Merriman previously served as chair of the company's audit committee from 2014 to 2018. "As the independent Chairman of the Board, Merriman succeeds Cliff Nastas as the company's lead independent director," report.  IVC stock jumps 9% in premarket on Monday to trade at $0.94 vs 52-week level of $0.80 to $8.73.
Seeking Alpha • Aug 23

Invacare adds two new directors after deal with largest investor Azurite

Medical equipment maker Invacare Corporation (NYSE:IVC) has appointed two new directors with immediate effect as part of a corporation agreement with its largest shareholder, Azurite Management LLC, which owns more than 10% of IVC stock. The new directors, Steven H. Rosen and Edward F. Crawford will replace Julie A. Beck and Stephanie L. Fehr, who resigned from the board on Aug. 22. Mr. Rosen is the Co-Founder, and Co-Chief Executive of Ohio-based private equity firm Resilience Capital Partners LLC. Crawford, a former U.S. ambassador to Ireland from 2019 to 2021, currently serves Resilience as a Member of its Board of Advisors. As part of the deal, IVC has agreed to set up a five-member Strategy and Operational Improvement Committee comprising the new appointees. The terms of the corporation agreement include certain standstill provisions which, among other things, will bar Azurite from raising its IVC stake above 19.9%.
分析記事 • Apr 30

Returns Are Gaining Momentum At Invacare (NYSE:IVC)

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
分析記事 • Jan 27

Invacare (NYSE:IVC) Use Of Debt Could Be Considered Risky

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
分析記事 • Dec 01

Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
分析記事 • Sep 30

Here's Why Invacare (NYSE:IVC) Is Weighed Down By Its Debt Load

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
分析記事 • Aug 06

When Should You Buy Invacare Corporation (NYSE:IVC)?

Invacare Corporation ( NYSE:IVC ), might not be a large cap stock, but it saw a decent share price growth in the teens...
分析記事 • May 14

Increases to CEO Compensation Might Be Put On Hold For Now at Invacare Corporation (NYSE:IVC)

In the past three years, the share price of Invacare Corporation ( NYSE:IVC ) has struggled to grow and now...
分析記事 • May 03

Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
分析記事 • Mar 03

Invacare Corporation's (NYSE:IVC) Path To Profitability

We feel now is a pretty good time to analyse Invacare Corporation's ( NYSE:IVC ) business as it appears the company may...
分析記事 • Feb 05

Invacare (NYSE:IVC) Has A Somewhat Strained Balance Sheet

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
分析記事 • Jan 10

What Can The Trends At Invacare (NYSE:IVC) Tell Us About Their Returns?

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
分析記事 • Dec 14

Invacare's(NYSE:IVC) Share Price Is Down 48% Over The Past Five Years.

It is a pleasure to report that the Invacare Corporation ( NYSE:IVC ) is up 33% in the last quarter. But over the last...
分析記事 • Nov 23

Invacare Corporation's (NYSE:IVC) Shift From Loss To Profit

With the business potentially at an important milestone, we thought we'd take a closer look at Invacare Corporation's...

株主還元

IVCR.QUS Medical EquipmentUS 市場
7D-10.6%2.7%0.6%
1Y-99.1%-11.6%20.1%

業界別リターン: IVCR.Q過去 1 年間で-11.6 % の収益を上げたUS Medical Equipment業界を下回りました。

リターン対市場: IVCR.Qは、過去 1 年間で20.1 % のリターンを上げたUS市場を下回りました。

価格変動

Is IVCR.Q's price volatile compared to industry and market?
IVCR.Q volatility
IVCR.Q Average Weekly Movement28.2%
Medical Equipment Industry Average Movement8.5%
Market Average Movement7.1%
10% most volatile stocks in US Market16.3%
10% least volatile stocks in US Market3.1%

安定した株価: IVCR.Qの株価は、 US市場と比較して過去 3 か月間で変動しています。

時間の経過による変動: IVCR.Qの weekly volatility ( 28% ) は過去 1 年間安定していますが、依然としてUSの株式の 75% よりも高くなっています。

会社概要

設立従業員CEO（最高経営責任者ウェブサイト
18852,800Geoff Purtillwww.invacare.com

Invacare Corporation 基礎のまとめ

Invacare の収益と売上を時価総額と比較するとどうか。
IVCR.Q 基礎統計学
時価総額US$512.81k
収益（TTM）-US$101.07m
売上高(TTM)US$741.73m
0.0x
P/Sレシオ
0.0x
PER（株価収益率

IVCR.Q は割高か？

公正価値と評価分析を参照

収益と収入

最新の決算報告書（TTM）に基づく主な収益性統計
IVCR.Q 損益計算書（TTM）
収益US$741.73m
売上原価US$557.69m
売上総利益US$184.04m
その他の費用US$285.12m
収益-US$101.07m

直近の収益報告

Dec 31, 2022

次回決算日

該当なし

一株当たり利益（EPS）-2.66
グロス・マージン24.81%
純利益率-13.63%
有利子負債／自己資本比率436.8%

IVCR.Q の長期的なパフォーマンスは？

過去の実績と比較を見る

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2023/05/05 11:52
終値2023/05/05 00:00
収益2022/12/31
年間収益2022/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Invacare Corporation これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。7

アナリスト機関
Robert LabickCJS Securities, Inc.
Constantine DavidesD. Boral Capital LLC.
Matthew MishanKeyBanc Capital Markets Inc.